Raj Kannan - Dec 20, 2021 Form 4 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role
Chief Executive Officer, Director
Signature
/s/ Raj Kannan
Stock symbol
AERI
Transactions as of
Dec 20, 2021
Transactions value $
$0
Form type
4
Date filed
12/22/2021, 07:07 PM
Previous filing
Aug 5, 2021
Next filing
Mar 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Award $0 +216K $0.00 216K Dec 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AERI Stock Option (right to buy) Award $0 +387K $0.00 387K Dec 20, 2021 Common Stock 387K $8.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Common Stock were granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan (the "Plan") and are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of December 20, 2021.
F2 This option was granted under the Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on December 20, 2022 and as to the remaining underlying shares in substantially equal installments on each of the subsequent 36 monthly anniversaries of December 20, 2022.